HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kristal D Atkins Selected Research

Neuroprotective Agents

3/2012Superior Neuroprotective Efficacy of LAU-0901, a Novel Platelet-Activating Factor Antagonist, in Experimental Stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kristal D Atkins Research Topics

Disease

5Ischemic Stroke
09/2012 - 09/2009
4Stroke (Strokes)
09/2012 - 01/2012
3Brain Ischemia (Cerebral Ischemia)
03/2012 - 09/2009
2Infarction (Infarctions)
09/2012 - 01/2012
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
07/2012
1Edema (Dropsy)
01/2012
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
07/2011

Drug/Important Bio-Agent (IBA)

5Docosahexaenoic AcidsIBA
09/2012 - 09/2009
3Fatty Acids (Saturated Fatty Acids)IBA
07/2012 - 03/2011
2protectin D1IBA
07/2012 - 01/2012
1Human Serum AlbuminFDA LinkGeneric
09/2012
1AlbuminsIBA
09/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2012
1EstersIBA
07/2012
1SaltsIBA
07/2012
1SodiumIBA
07/2012
1Platelet Activating FactorIBA
03/2012
1Neuroprotective AgentsIBA
03/2012
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
01/2012
1Amphetamine (Amfetamine)FDA LinkGeneric
07/2011
1Methylphenidate (Ritalin)FDA LinkGeneric
07/2011

Therapy/Procedure

3Therapeutics
09/2012 - 03/2011
1Intravenous Administration
07/2012
1Investigational Therapies (Experimental Therapy)
09/2009